Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Multiple Sclerosis in Children

Remyelination Strategies for Multiple Sclerosis

Early Signs of Multiple Sclerosis

Benign Multiple Sclerosis (MS)

Primary Progressive Multiple Sclerosis (PPMS)

Multiple sclerosis and beta interferon

Types of Multiple Sclerosis (MS)

Epigenetics for Multiple Sclerosis

What Causes Multiple Sclerosis?

See more featured articles »

Cognitive Impairment and Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Anti-Myelin Antibodies in Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS)

At-Home Physiotherapy Exercises for Multiple Sclerosis

Heat Intolerance in Multiple Sclerosis

Multiple Sclerosis and Pregnancy

Multiple Sclerosis Epidemiology

Working Towards Earlier Diagnosis of Multiple Sclerosis

Multiple sclerosis and smoking

Multiple Sclerosis and Women’s Health

Optic Neuritis and Multiple Sclerosis

Secondary Progressive Multiple Sclerosis (SPMS)

Latest Multiple Sclerosis News and Research

Frequent soccer heading linked to alterations within the folds of the brain

In amateur soccer players, more frequent heading, or using the head to control or pass the ball, is linked to alterations within the folds of the brain, according to a study published on September 17, 2025, in Neurology, the medical journal of the American Academy of Neurology.

17 Sep 2025

Physical frailty linked to higher dementia risk

A new study suggests that physical frailty may contribute to the development of dementia. The study was published on September 17, 2025, in Neurology®, the medical journal of the American Academy of Neurology.

17 Sep 2025

Researchers receive new funding to advance promising therapy for multiple sclerosis

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance a promising therapy for multiple sclerosis (MS).

15 Sep 2025

A universal solution emerges: Anti-linker antibodies simplify CAR-T detection and development

CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors.

From Sino Biological Inc. 13 Sep 2025

Chronic insomnia linked to faster cognitive decline and brain changes

People with chronic insomnia may experience faster declines in memory and thinking skills as they age-along with brain changes that can be seen on imaging scans-than people who do not have chronic insomnia, according to a study published in the September 10, 2025, issue of Neurology, the medical journal of the American Academy of Neurology.

10 Sep 2025

Understanding how mRNA stability influences immune diseases

A pizza shop with 30 delivery people ought to be able to deliver a lot of pizzas - if their cars don't break down on the way.

5 Sep 2025

Hidden protein particle in COVID virus may lead to longer-lasting vaccines

A protein particle hidden within the SARS-CoV-2 virus could lead to longer-lasting, more protective vaccines for COVID-19.

4 Sep 2025

Study links high intake of artificial sweeteners to faster cognitive decline

Some sugar substitutes may come with unexpected consequences for long-term brain health, according to a study published in the September 3, 2025, issue of Neurology, the medical journal of the American Academy of Neurology.

3 Sep 2025

Researchers reveal how diseases interact at the genetic level

2 Sep 2025

Why metformin could protect the brain by rewiring mitochondria

Metformin boosts human oligodendrocyte differentiation and myelination across stem-cell, organoid, and chimera models. The study links these effects to mitochondrial metabolic shifts, supporting its potential as a therapy for multiple sclerosis.

1 Sep 2025

Alzheimer’s research uncovers a new therapeutic pathway for the memory-robbing malady

The gut contains the largest collection of immune cells in the body. New research at the Buck Institute shows that some of those immune cells travel along the brain/gut axis in a mouse model of Alzheimer's disease (AD) providing a potential new therapeutic pathway for the memory-robbing malady.

29 Aug 2025

Native Hawaiian and Pacific Islander people face highest stroke rates in the U.S.

A new study found that Native Hawaiian or Pacific Islander people had the highest rate of stroke among people from other race and ethnic groups, with a rate more than three times higher than that of white people.

28 Aug 2025

Hormone therapy type may influence postmenopausal cognitive health

The type of estradiol-based hormone therapy taken during and after menopause, such as patches or pills, may be associated with differences in memory performance, according to a study published on August 27, 2025, in Neurology, the medical journal of the American Academy of Neurology.

28 Aug 2025

Most US neurologists prescribing multiple sclerosis drugs receive pharma industry payments

Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5 year analysis of Medicare database payments, published in the open access journal BMJ Open.

27 Aug 2025

Unlocking neuroglia’s potential to halt neurodegeneration and restore brain homeostasis

In a revealing Genomic Press Interview published today in Brain Medicine, Professor Alexei Verkhratsky dismantles decades of neuroscience orthodoxy with discoveries that position neuroglia as active architects of brain function rather than passive cellular bystanders.

26 Aug 2025

Scientists discover molecular brake that halts brain cell repair in multiple sclerosis

A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University's School of Medicine has discovered a built-in "brake" that controls when key brain cells mature.

25 Aug 2025

Aston Medical School secures NIHR funding for 12 academic clinical fellows

Aston Medical School has successfully bid for funding from the National Institute for Health and Care Research (NIHR) for 12 Academic Clinical Fellows.

22 Aug 2025

Investigation raises concerns over tooth stem cell banking claims

Parents are spending thousands of pounds to bank stem cells from their children's milk teeth – but the recipient companies' claims about their future medical value are unproven and potentially misleading, reveals an investigation by The BMJ, published today.

21 Aug 2025

Metabolic syndrome linked to higher risk of Parkinson's disease

Having a larger waistline, high blood pressure and other risk factors that make up metabolic syndrome is associated with an increased risk of Parkinson's disease, according to a study published on August 20, 2025, in Neurology, the medical journal of the American Academy of Neurology.

20 Aug 2025

Mitochondrial dysfunction in the blood-brain barrier may contribute to neuropsychiatric disease in 22qDS

In a new study led by the University of Pennsylvania School of Veterinary Medicine (Penn Vet) and Children's Hospital of Philadelphia (CHOP), researchers found that mitochondrial dysfunction in the blood-brain barrier (BBB) may lead to neuropsychiatric disease in some patients with 22qDS.

20 Aug 2025